Page last updated: 2024-08-24

squaric acid dibutyl ester and Delayed Hypersensitivity

squaric acid dibutyl ester has been researched along with Delayed Hypersensitivity in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freyschmidt-Paul, P; Mueller, U; Singh, V; Zöller, M1
Diaferio, A; Lopalco, PL; Mastrolonardo, M1
Freyschmidt-Paul, P; Hoffmann, R; Hummel, S; McElwee, KJ; Vitacolonna, M; Zöller, M1
Baniyash, M; Freyschmidt-Paul, P; Hildebrand, D; Marhaba, R; Vitacolonna, M; Zöller, M1
Bröcker, EB; Hamm, H; John, SM; Steinhausen, D1

Other Studies

5 other study(ies) available for squaric acid dibutyl ester and Delayed Hypersensitivity

ArticleYear
Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells.
    European journal of immunology, 2011, Volume: 41, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Alopecia Areata; Animals; Apoptosis; Autoimmune Diseases; Autoimmunity; CD4-CD8 Ratio; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclobutanes; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mitochondria; Myeloid Cells; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptors, Antigen, T-Cell; Receptors, Tumor Necrosis Factor; Signal Transduction; T-Lymphocytes; Tretinoin; Tumor Necrosis Factor-alpha

2011
Topical immunotherapy with contact sensitizers: a model to study the natural history of delayed hypersensitivity.
    Contact dermatitis, 2002, Volume: 47, Issue:4

    Topics: Administration, Topical; Alopecia; Cohort Studies; Cyclobutanes; Dermatitis, Allergic Contact; Desensitization, Immunologic; Female; Follow-Up Studies; Humans; Hypersensitivity, Delayed; Immunotherapy; Male; Probability; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Warts

2002
Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
    Clinical and experimental immunology, 2004, Volume: 135, Issue:3

    Topics: Allergens; Alopecia Areata; Animals; Autoimmune Diseases; Cells, Cultured; Cyclobutanes; Hypersensitivity, Delayed; Immunophenotyping; Immunotherapy; Leukocytes; Lymph Nodes; Mice; Mice, Inbred C3H; Skin; T-Lymphocyte Subsets

2004
The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Oct-15, Volume: 179, Issue:8

    Topics: Allergens; Alopecia Areata; Animals; Autoimmune Diseases; Chronic Disease; Cyclobutanes; Dermatitis, Contact; Down-Regulation; Hypersensitivity, Delayed; Membrane Proteins; Mice; Mice, Inbred C3H; Myeloid Cells; Receptors, Antigen, T-Cell; T-Lymphocytes, Regulatory

2007
Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
    Archives of dermatological research, 1991, Volume: 283, Issue:2

    Topics: Administration, Cutaneous; Adolescent; Adult; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Male; Middle Aged

1991